Volociximab (Anti-Integrin a5b1 (ITGA5 & ITGB1))

Volociximab (Anti-Integrin a5b1 (ITGA5 & ITGB1)) is a monoclonal antibody targeting Integrin a5b1 (ITGA5 & ITGB1). It can be used in treatment of solid tumors, renal cell carcinoma, melanoma, pancreatic cancer, lung cancer, and ovarian cancer. MW :145.52 KD.
Supplier Selleck Chemicals
Product # A3106
Sku # A3106-1mg
Pricing 1mg, $539.00
Feedback